Akso Health Group Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
Forward P/E5.085.085.085.085.08
P/S Ratio28.7770.290.626.44
P/B Ratio2.131.230.923.151.74
Price/Tangible Book2.361.230.933.151.74
Price/FCF415.76125.592.99
Price/OCF361.20125.592.99
PEG Ratio0.510.510.510.510.51
Enterprise Value Ratios
EV/Revenue22.9270.650.595.86
EV/FCF331.15126.242.80
Profitability & Returns
Return on Equity (ROE)-0.80%-0.12%-1.24%-0.28%-0.13%
Return on Assets (ROA)-0.01%-0.07%-0.21%-0.03%-0.02%
Return on Invested Capital (ROIC)-0.10%-0.26%-0.69%-0.11%-0.05%
Return on Capital Employed (ROCE)-0.02%-0.06%-1.61%-0.20%-0.12%
Leverage & Solvency Ratios
Debt/Equity0.010.011.103.030.75
Debt/FCF2.041.481.29
Liquidity Ratios
Current Ratio14.2039.521.761.242.09
Quick Ratio12.8323.701.340.361.67
Efficiency Ratios
Asset Turnover0.080.030.320.13
Inventory Turnover78.962.442.51
Yield & Distribution Ratios
Earnings Yield-0.32%-0.06%-0.17%-0.44%-1.16%
FCF Yield0.00%0.01%-0.40%-0.22%0.33%
Buyback Yield-5.04%-1.06%-0.15%-0.22%0.00%
Total Return-5.04%-1.06%-0.15%-0.22%0.00%